Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Houben

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 1, 2006
[New therapeutic approaches for solid tumors: histone deacetylase, methyltransferase and proteasome inhibitors]Jürgen C Becker, Selma Ugurel, Eva-Bettina Bröcker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylateUta B Hofmann, Claudia S Kauczok-Vetter, Roland Houben, et al.
The Journal of Investigative Dermatology|August 19, 2011
Merkel cell carcinoma and Merkel cell polyomavirus: evidence for hit-and-run oncogenesisRoland Houben, Johannes Grimm, Christoph Willmes, et al.
The Journal of Investigative Dermatology|October 9, 2009
Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogenePatrick Terheyden, Roland Houben, Parisa Pajouh, et al.
Molecular Cancer Therapeutics|February 5, 2009
MAPK-independent impairment of T-cell responses by the multikinase inhibitor sorafenibRoland Houben, Heike Voigt, Christiane Noelke, et al.
The Journal of Investigative Dermatology|October 16, 2009
Lack of correlation between IGFBP7 expression and BRAF mutational status in melanomaDavid Schrama, Hermann Kneitz, Christoph Willmes, et al.
The Journal of Investigative Dermatology|July 18, 2008
MC polyomavirus is frequently present in Merkel cell carcinoma of European patientsJürgen C Becker, Roland Houben, Selma Ugurel, et al.
Archives of Dermatology|June 23, 2010
Distinction of 2 different primary Merkel cell carcinomas in 1 patient by Merkel cell polyomavirus genome analysisDavid Schrama, Anja Thiemann, Roland Houben, et al.
Experimental Dermatology|October 24, 2009
Mouse models for melanoma: a personal perspectiveJürgen C Becker, Roland Houben, David Schrama, et al.
Oncogenesis|September 22, 2018
BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1Johannes Grimm, Anita Hufnagel, Marion Wobser, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 1, 2006
[New therapeutic approaches for solid tumors: histone deacetylase, methyltransferase and proteasome inhibitors]Jürgen C Becker, Selma Ugurel, Eva-Bettina Bröcker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylateUta B Hofmann, Claudia S Kauczok-Vetter, Roland Houben, et al.
The Journal of Investigative Dermatology|August 19, 2011
Merkel cell carcinoma and Merkel cell polyomavirus: evidence for hit-and-run oncogenesisRoland Houben, Johannes Grimm, Christoph Willmes, et al.
The Journal of Investigative Dermatology|October 9, 2009
Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogenePatrick Terheyden, Roland Houben, Parisa Pajouh, et al.
Molecular Cancer Therapeutics|February 5, 2009
MAPK-independent impairment of T-cell responses by the multikinase inhibitor sorafenibRoland Houben, Heike Voigt, Christiane Noelke, et al.
The Journal of Investigative Dermatology|October 16, 2009
Lack of correlation between IGFBP7 expression and BRAF mutational status in melanomaDavid Schrama, Hermann Kneitz, Christoph Willmes, et al.
The Journal of Investigative Dermatology|July 18, 2008
MC polyomavirus is frequently present in Merkel cell carcinoma of European patientsJürgen C Becker, Roland Houben, Selma Ugurel, et al.
Archives of Dermatology|June 23, 2010
Distinction of 2 different primary Merkel cell carcinomas in 1 patient by Merkel cell polyomavirus genome analysisDavid Schrama, Anja Thiemann, Roland Houben, et al.
Experimental Dermatology|October 24, 2009
Mouse models for melanoma: a personal perspectiveJürgen C Becker, Roland Houben, David Schrama, et al.
Oncogenesis|September 22, 2018
BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1Johannes Grimm, Anita Hufnagel, Marion Wobser, et al.
Pageof 11